CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 31 filers reported holding CASI PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $5,000 | -84.4% | 2,262 | -78.6% | 0.00% | – |
| Q4 2020 | $32,000 | +540.0% | 10,588 | +243.8% | 0.00% | – |
| Q3 2020 | $5,000 | -50.0% | 3,080 | -28.4% | 0.00% | – |
| Q2 2020 | $10,000 | -50.0% | 4,301 | -33.9% | 0.00% | – |
| Q4 2019 | $20,000 | +33.3% | 6,507 | +47.1% | 0.00% | – |
| Q3 2019 | $15,000 | +7.1% | 4,423 | +3.6% | 0.00% | – |
| Q2 2019 | $14,000 | +366.7% | 4,271 | +506.7% | 0.00% | – |
| Q4 2018 | $3,000 | +50.0% | 704 | +104.7% | 0.00% | – |
| Q3 2018 | $2,000 | -33.3% | 344 | -2.8% | 0.00% | – |
| Q2 2018 | $3,000 | – | 354 | +293.3% | 0.00% | – |
| Q2 2016 | $0 | – | 90 | 0.0% | 0.00% | – |
| Q1 2016 | $0 | – | 90 | 0.0% | 0.00% | – |
| Q4 2015 | $0 | – | 90 | +150.0% | 0.00% | – |
| Q1 2015 | $0 | – | 36 | 0.0% | 0.00% | – |
| Q4 2014 | $0 | – | 36 | 0.0% | 0.00% | – |
| Q3 2014 | $0 | – | 36 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IDG-Accel China Growth Fund III Associates L.P. | 7,973,536 | $19,934,000 | 16.36% |
| Wellington Shields & Co., LLC | 1,585,609 | $3,964,000 | 1.74% |
| Wellington Shields Capital Management, LLC | 1,321,745 | $3,304,000 | 0.53% |
| Ikarian Capital, LLC | 1,039,910 | $2,600,000 | 0.21% |
| Zebra Capital Management LLC | 50,658 | $127,000 | 0.18% |
| BOOTHBAY FUND MANAGEMENT, LLC | 139,183 | $348,000 | 0.02% |
| Manatuck Hill Partners, LLC | 15,090 | $38,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 205,200 | $513,000 | 0.01% |
| IHT Wealth Management, LLC | 26,000 | $65,000 | 0.01% |
| Vident Investment Advisory, LLC | 67,540 | $169,000 | 0.01% |